Cannabis
CORRECTION: Steep Hill Inc. Provides An Update
This document corrects and replaces the press release that was issued by Steep Hill Inc. earlier today. The error occurred in the headline where it should have read, “Steep Hill Inc. Provides An Update” instead of “Steel Hill Inc. Provides An Update”. No other changes were required in the body of the release.
Toronto, Ontario–(Newsfile Corp. – July 25, 2022) – Steep Hill Inc. (CSE: STPH) (“Steep Hill” or the “Company“), a leading cannabis science and technology company, was named as one of several defendants in a complaint filed in the United States District Court for the Eastern District of Arkansas. The complaint, brought by purchasers of medical marijuana in Arkansas, on behalf of a proposed class, alleges that the Company’s licensee, Steep Hill Arkansas, and Arkansas based cannabis cultivators, violated federal laws prohibiting the cultivation and sale of marijuana and overstated the amount of THC in certain cannabis products.
Steep Hill Arkansas is an independent operator, licensed to conduct cannabis testing in Arkansas under the Steep Hill brand. Steep Hill stands by the quality of its laboratory methodologies which are industry leading, believes the claims filed against it are meritless, and intends to promptly move to dismiss the complaint.
ABOUT STEEP HILL
Steep Hill is a science and technology company focused on providing products and services, including analytical testing services within the hemp and cannabis market sectors. The Company’s focus is on two areas: science and technology, by providing science-backed differentiated products and services that are critical within these sectors; and quality and compliance, by offering services that assist its customers to offer products and services that meet expected standards of quality, safety and compliance.
For further information, please contact:
Raj Ravindran – CFO
Christian Poole – VP of IR | Phone: (510) 562-74000 | [email protected]
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/131784
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Cannabis2 weeks ago
Geopulse Exploration, Inc. Acquires 50% of ATC Services
-
transfer1 week ago
IMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis1 week ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
Cannabis6 days ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis7 days ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
CCELL®1 week ago
CCELL Launches Environmentally Conscious Eco Star AIO Vaporizer
-
Innocan3 days ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf3 days ago
Curaleaf Completes Acquisition of Northern Green Canada